2094 Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type metastatic colorectal cancer: HGCSG1001 (Japanese Skin Toxicity Evaluation Protocol With Panitumumab: J-STEPP): Updated analysis of anti-tumor efficacy. (September 2015) - Kobayashi, Y.; Yuki, S.; Kawamoto, Y.; Sawada, K.; Miyagishima, T.; Ehira, N.; Iwanaga, I.; Okuda, H.; Tateyama, M.; Tsuji, Y.; Hatanaka, K.; Nakamura, M.; et al.